tiprankstipranks
Humana (HUM)
NYSE:HUM
US Market
HUM
Humana
RESEARCH TOOLSreports
Want to see HUM full AI Analyst Report?

Humana (HUM) Stock Forecast & Price Target

2,714 Followers
See the Price Targets and Ratings of:

HUM Analyst Ratings

Hold
19Ratings
Hold
6 Buy
11 Hold
2 Sell
Based on 19 analysts giving stock ratings to
Humana
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HUM Stock 12 Month Forecast

Average Price Target

$294.56
▲(43.59% Upside)
Based on 19 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $294.56 with a high forecast of $441.00 and a low forecast of $195.00. The average price target represents a 43.59% change from the last price of $205.14.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"175":"$175","442":"$442","241.75":"$241.8","308.5":"$308.5","375.25":"$375.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":441,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$441.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":294.55555555555554,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$294.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":195,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$195.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[175,241.75,308.5,375.25,442],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,409.42,411.84923076923076,414.27846153846156,416.7076923076923,419.1369230769231,421.56615384615384,423.99538461538464,426.4246153846154,428.8538461538462,431.2830769230769,433.7123076923077,436.14153846153846,438.5707692307692,{"y":441,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,409.42,400.58427350427354,391.748547008547,382.91282051282053,374.07709401709405,365.2413675213675,356.40564102564105,347.5699145299145,338.73418803418804,329.89846153846156,321.062735042735,312.22700854700855,303.391282051282,{"y":294.55555555555554,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,409.42,392.92615384615385,376.4323076923077,359.9384615384615,343.4446153846154,326.9507692307692,310.4569230769231,293.9630769230769,277.46923076923076,260.9753846153846,244.48153846153843,227.9876923076923,211.49384615384614,{"y":195,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":248.987,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.742,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":299.34,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":244.109,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.19,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":239.617,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":254.235,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.815,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.895,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":176.533,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":233.08,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.537,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":409.42,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$441.00Average Price Target$294.56Lowest Price Target$195.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on HUM
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$340→$380
Hold
85.24%
Upside
Reiterated
06/24/26
Analysts Offer Insights on Healthcare Companies: Cencora (NYSE: COR), UnitedHealth (NYSE: UNH) and Humana (NYSE: HUM)
Bernstein Analyst forecast on HUM
Lance Wilkes
Bernstein
Bernstein
$425
Buy
107.18%
Upside
Reiterated
06/09/26
Analysts Offer Insights on Healthcare Companies: Verastem (NASDAQ: VSTM), Jazz Pharmaceuticals (NASDAQ: JAZZ) and Humana (NYSE: HUM)
Mizuho Securities Analyst forecast on HUM
Ann Hynes
Mizuho Securities
Mizuho Securities
$335→$390
Buy
90.11%
Upside
Reiterated
06/08/26
Humana price target raised to $390 from $335 at MizuhoHumana price target raised to $390 from $335 at Mizuho
J.P. Morgan Analyst forecast on HUM
Lisa Gill
J.P. Morgan
J.P. Morgan
$214→$316
Hold
54.04%
Upside
Reiterated
06/08/26
Humana price target raised to $316 from $214 at JPMorganHumana price target raised to $316 from $214 at JPMorgan
Morgan Stanley Analyst forecast on HUM
Erin Wright
Morgan Stanley
Morgan Stanley
$217→$249
Sell
21.38%
Upside
Assigned
06/04/26
Humana price target raised to $249 from $217 at Morgan StanleyHumana price target raised to $249 from $217 at Morgan Stanley
Wells Fargo Analyst forecast on HUM
Stephen Baxter
Wells Fargo
Wells Fargo
$227
Hold
10.66%
Upside
Reiterated
06/04/26
Humana (HUM) Receives a Hold from Wells Fargo
Truist Financial Analyst forecast on HUM
David S Macdonald
Truist Financial
Truist Financial
$270→$320
Hold
55.99%
Upside
Assigned
06/01/26
Humana price target raised to $320 from $270 at TruistHumana price target raised to $320 from $270 at Truist
Barclays Analyst forecast on HUM
Andrew Mok CFA
Barclays
Barclays
$180→$344
Hold
67.69%
Upside
Reiterated
05/26/26
Humana price target raised to $344 from $180 at BarclaysHumana price target raised to $344 from $180 at Barclays
UBS Analyst forecast on HUM
A.J. Rice
UBS
UBS
$262→$320
Hold
55.99%
Upside
Reiterated
05/22/26
Humana price target raised to $320 from $262 at UBSHumana price target raised to $320 from $262 at UBS
Deutsche Bank Analyst forecast on HUM
George Hill
Deutsche Bank
Deutsche Bank
$235→$441
Buy
114.98%
Upside
Upgraded
05/20/26
Humana upgraded to Buy from Hold at Deutsche BankHumana upgraded to Buy from Hold at Deutsche Bank
Piper Sandler Analyst forecast on HUM
Jessica Tassan
Piper Sandler
Piper Sandler
$182→$254
Hold
23.82%
Upside
Reiterated
05/13/26
Humana price target raised to $254 from $182 at Piper SandlerHumana price target raised to $254 from $182 at Piper Sandler
Raymond James Analyst forecast on HUM
John Ransom
Raymond James
Raymond James
$230→$260
Buy
26.74%
Upside
Reiterated
05/01/26
Humana price target raised to $260 from $230 at Raymond JamesHumana price target raised to $260 from $230 at Raymond James
TD Cowen Analyst forecast on HUM
Ryan Langston
TD Cowen
TD Cowen
$173→$211
Hold
2.86%
Upside
Assigned
05/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cartesian Therapeutics (NASDAQ: RNAC) and Humana (NYSE: HUM)
Oppenheimer Analyst forecast on HUM
Michael Wiederhorn
Oppenheimer
Oppenheimer
$250→$260
Buy
26.74%
Upside
Reiterated
04/30/26
Humana price target raised to $260 from $250 at OppenheimerHumana price target raised to $260 from $250 at Oppenheimer
Goldman Sachs Analyst forecast on HUM
Scott Fidel
Goldman Sachs
Goldman Sachs
$158→$195
Sell
-4.94%
Downside
Reiterated
04/30/26
Humana price target raised to $195 from $158 at Goldman SachsHumana price target raised to $195 from $158 at Goldman Sachs
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on HUM
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$340→$380
Hold
85.24%
Upside
Reiterated
06/24/26
Analysts Offer Insights on Healthcare Companies: Cencora (NYSE: COR), UnitedHealth (NYSE: UNH) and Humana (NYSE: HUM)
Bernstein Analyst forecast on HUM
Lance Wilkes
Bernstein
Bernstein
$425
Buy
107.18%
Upside
Reiterated
06/09/26
Analysts Offer Insights on Healthcare Companies: Verastem (NASDAQ: VSTM), Jazz Pharmaceuticals (NASDAQ: JAZZ) and Humana (NYSE: HUM)
Mizuho Securities Analyst forecast on HUM
Ann Hynes
Mizuho Securities
Mizuho Securities
$335→$390
Buy
90.11%
Upside
Reiterated
06/08/26
Humana price target raised to $390 from $335 at MizuhoHumana price target raised to $390 from $335 at Mizuho
J.P. Morgan Analyst forecast on HUM
Lisa Gill
J.P. Morgan
J.P. Morgan
$214→$316
Hold
54.04%
Upside
Reiterated
06/08/26
Humana price target raised to $316 from $214 at JPMorganHumana price target raised to $316 from $214 at JPMorgan
Morgan Stanley Analyst forecast on HUM
Erin Wright
Morgan Stanley
Morgan Stanley
$217→$249
Sell
21.38%
Upside
Assigned
06/04/26
Humana price target raised to $249 from $217 at Morgan StanleyHumana price target raised to $249 from $217 at Morgan Stanley
Wells Fargo Analyst forecast on HUM
Stephen Baxter
Wells Fargo
Wells Fargo
$227
Hold
10.66%
Upside
Reiterated
06/04/26
Humana (HUM) Receives a Hold from Wells Fargo
Truist Financial Analyst forecast on HUM
David S Macdonald
Truist Financial
Truist Financial
$270→$320
Hold
55.99%
Upside
Assigned
06/01/26
Humana price target raised to $320 from $270 at TruistHumana price target raised to $320 from $270 at Truist
Barclays Analyst forecast on HUM
Andrew Mok CFA
Barclays
Barclays
$180→$344
Hold
67.69%
Upside
Reiterated
05/26/26
Humana price target raised to $344 from $180 at BarclaysHumana price target raised to $344 from $180 at Barclays
UBS Analyst forecast on HUM
A.J. Rice
UBS
UBS
$262→$320
Hold
55.99%
Upside
Reiterated
05/22/26
Humana price target raised to $320 from $262 at UBSHumana price target raised to $320 from $262 at UBS
Deutsche Bank Analyst forecast on HUM
George Hill
Deutsche Bank
Deutsche Bank
$235→$441
Buy
114.98%
Upside
Upgraded
05/20/26
Humana upgraded to Buy from Hold at Deutsche BankHumana upgraded to Buy from Hold at Deutsche Bank
Piper Sandler Analyst forecast on HUM
Jessica Tassan
Piper Sandler
Piper Sandler
$182→$254
Hold
23.82%
Upside
Reiterated
05/13/26
Humana price target raised to $254 from $182 at Piper SandlerHumana price target raised to $254 from $182 at Piper Sandler
Raymond James Analyst forecast on HUM
John Ransom
Raymond James
Raymond James
$230→$260
Buy
26.74%
Upside
Reiterated
05/01/26
Humana price target raised to $260 from $230 at Raymond JamesHumana price target raised to $260 from $230 at Raymond James
TD Cowen Analyst forecast on HUM
Ryan Langston
TD Cowen
TD Cowen
$173→$211
Hold
2.86%
Upside
Assigned
05/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cartesian Therapeutics (NASDAQ: RNAC) and Humana (NYSE: HUM)
Oppenheimer Analyst forecast on HUM
Michael Wiederhorn
Oppenheimer
Oppenheimer
$250→$260
Buy
26.74%
Upside
Reiterated
04/30/26
Humana price target raised to $260 from $250 at OppenheimerHumana price target raised to $260 from $250 at Oppenheimer
Goldman Sachs Analyst forecast on HUM
Scott Fidel
Goldman Sachs
Goldman Sachs
$158→$195
Sell
-4.94%
Downside
Reiterated
04/30/26
Humana price target raised to $195 from $158 at Goldman SachsHumana price target raised to $195 from $158 at Goldman Sachs
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

3 Months
Michael WiederhornOppenheimer
Success Rate
25/39 ratings generated profit
64%
Average Return
+4.06%
Copying Michael Wiederhorn's trades and holding each position for 3 Months would result in 64.10% of your transactions generating a profit, with an average return of +4.06% per trade.
1 Year
Michael WiederhornOppenheimer
Success Rate
24/39 ratings generated profit
62%
Average Return
+10.48%
Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +10.48% per trade.
2 Years
Michael WiederhornOppenheimer
Success Rate
31/39 ratings generated profit
79%
Average Return
+21.46%
Copying Michael Wiederhorn's trades and holding each position for 2 Years would result in 79.49% of your transactions generating a profit, with an average return of +21.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
1
0
0
0
0
Buy
11
11
11
13
7
Hold
24
34
19
24
10
Sell
3
4
2
3
2
Strong Sell
0
0
0
0
0
total
39
49
32
40
19
In the current month, HUM has received 7 Buy Ratings, 10 Hold Ratings, and 2 Sell Ratings. HUM average Analyst price target in the past 3 months is 294.56.
Each month's total comprises the sum of three months' worth of ratings.

HUM Financial Forecast

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is $7.23 with a range of $5.39 to $7.68. The previous quarter’s EPS was $10.31. HUM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.
Next quarter’s earnings estimate for HUM is $7.23 with a range of $5.39 to $7.68. The previous quarter’s EPS was $10.31. HUM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Sales Forecast

Next quarter’s sales forecast for HUM is $40.56B with a range of $40.00B to $41.30B. The previous quarter’s sales results were $39.65B. HUM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.
Next quarter’s sales forecast for HUM is $40.56B with a range of $40.00B to $41.30B. The previous quarter’s sales results were $39.65B. HUM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Stock Forecast FAQ

What is HUM’s average 12-month price target, according to analysts?
Based on analyst ratings, Humana’s 12-month average price target is 294.56.
    What is HUM’s upside potential, based on the analysts’ average price target?
    Humana has 43.59% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is HUM a Buy, Sell or Hold?
          Humana has a consensus rating of Hold which is based on 6 buy ratings, 11 hold ratings and 2 sell ratings.
            What is Humana’s price target?
            The average price target for Humana is 294.56. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $441.00 ,the lowest forecast is $195.00. The average price target represents 43.59% Increase from the current price of $205.14.
              What do analysts say about Humana?
              Humana’s analyst rating consensus is a Hold. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of HUM?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.